Consistent with our study, ATG5 and PRKN were identified as risk genes (27, 29, 30), whereas, CDKN2A and NLRP1 predicted favorable survivals of HNSCC (28–33). The gene discussed is PRKN; the disease is head and neck squamous cell carcinoma.